Search Results 1331-1340 of 20152 for Hepatitis C

1. Patient Stories - Peter C. Rhee, D.O., M.S. - Mayo Clinic

   Peter C. Rhee, D.O., M.S. · Hand Surgeon · Orthopedic Surgeon.

2. A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Participants who are hepatitis C antibody positive will need to have a negative PCR result before randomization. Those who are hepatitis C PCR positive will be ...

3. Mayo Clinic Transplant Center - Doctors

   Displaying 11-14 out of 14 doctors available. Last Name Initial: C,C. Alex Cortez, M.D.. Transplant Surgeon. Rochester, MN. Areas of focus ...

4. Efficacy And Safety Of Maribavir In Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory Or Resistant To Treatment - Mayo Clinic

   Undergoing treatment for acute or chronic hepatitis C. Have any clinically significant medical or surgical condition that, in the Investigator's opinion ...

5. A Study to Evaluate Chemoradiotherapy with or without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer - Mayo Clinic

   If patient has a known history of hepatitis B virus (HBV) or hepatitis C ... hepatitis B core antigen] antibody test) are eligible;; Patients positive for ...

6. Emricasan, A Caspase Inhibitor, For Evaluation In Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

   Alcoholic steatohepatitis · Autoimmune hepatitis · Hepatitis B virus (HBV) infection · Hepatitis C virus (HCV) infection · Primary biliary cirrhosis · Primary ...

7. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   ... hepatitis B infection (HBsAg or HBeAg positive) or positive hepatitis C serology, as further severe immunosuppression with this regimen may occur; Evidence ...

8. Transforming noninvasive liver disease detection by MRE: the hepatogram - Mayo Clinic

   ... hepatitis and congestion associated with cardiac hepatopathy. Detection of these changes provides essential diagnostic, prognostic and treatment information ...

9. A Study of the Safety and Effectiveness of HBI-8000 with Nivolumab to Treat Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer - Mayo Clinic

   Active hepatitis B (serum hepatitis B surface antigen [HBV sAg] positive), or hepatitis C (hepatitis C virus [HCV] antibody test or serum hepatitis C ...

10. A Study To Evaluate The Impact On Metastases-free Survival With The Addition Of Saruparib Versus Placebo To A Standard Radiotherapy/androgen Deprivation Regimen In Men With High-risk Prostate Cancer With A BRCA Mutation. - Mayo Clinic

    Evidence of active and uncontrolled hepatitis B and/or hepatitis C. Screening for hepatitis B and hepatitis C is not required. Participants previously ...